| C548651 | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of NRP2 mRNA | 19933214 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in increased expression of NRP2 mRNA" | 23146750 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in increased expression of NRP2 mRNA" | 27291303 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of NRP2 mRNA" | 23146750 |
| C583074 | 4,4'-hexafluorisopropylidene diphenol | "4,4'-hexafluorisopropylidene diphenol results in increased expression of NRP2 mRNA" | 27567155 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA" | 27188386 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of NRP2 mRNA | 16483693 |
| D018501 | Antirheumatic Agents | Antirheumatic Agents results in decreased expression of NRP2 mRNA | 24449571 |
| D001104 | Arbutin | Arbutin results in increased expression of NRP2 mRNA | 17103032 |
| D001151 | Arsenic | Arsenic affects the expression of NRP2 protein | 24675094 |
| D001151 | Arsenic | Arsenic affects the methylation of NRP2 gene | 25304211 |
| D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in decreased expression of NRP2 mRNA" | 18687144 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of NRP2 mRNA | 22300585 |
| C006780 | bisphenol A | bisphenol A results in increased expression of NRP2 mRNA | 29275510 |
| C006780 | bisphenol A | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRP2 mRNA | 28628672 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of NRP2 mRNA | 25181051 |
| D000074262 | Canola Oil | Canola Oil metabolite results in decreased expression of NRP2 mRNA | 27363782 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the expression of NRP2 mRNA | 17484886 |
| D002713 | Chlorine | [Ozone co-treated with Chlorine] results in increased expression of NRP2 mRNA | 18636392 |
| D002737 | Chloroprene | Chloroprene results in decreased expression of NRP2 mRNA | 23125180 |
| D002752 | Chlorthalidone | Chlorthalidone results in decreased expression of NRP2 mRNA | 20625077 |
| C018021 | cobaltous chloride | cobaltous chloride results in decreased expression of NRP2 mRNA | 19320972 |
| D003042 | Cocaine | Cocaine results in increased expression of NRP2 mRNA | 15691709 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in increased expression of NRP2 mRNA | 18632792 |
| D000069439 | Dasatinib | Dasatinib results in increased expression of NRP2 mRNA | 20579391 |
| C010902 | decabromobiphenyl ether | decabromobiphenyl ether results in increased expression of NRP2 mRNA | 23640034 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRP2 mRNA | 28628672 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in increased expression of NRP2 mRNA | 17361019 |
| D002945 | Cisplatin | Cisplatin results in increased expression of NRP2 mRNA | 27392435 |
| C000944 | dicrotophos | dicrotophos results in increased expression of NRP2 mRNA | 28302478 |
| D002117 | Calcitriol | Calcitriol results in decreased expression of NRP2 mRNA | 16002434 |
| D002117 | Calcitriol | Calcitriol results in increased expression of NRP2 mRNA | 16002434 |
| C118739 | entinostat | entinostat results in increased expression of NRP2 mRNA | 26272509 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA" | 27188386 |
| D004397 | Fonofos | Fonofos results in increased methylation of NRP2 promoter | 22847954 |
| C039281 | furan | furan results in decreased expression of NRP2 mRNA | 24183702 |
| C039281 | furan | furan results in increased methylation of NRP2 gene | 22079235 |
| D019833 | Genistein | Genistein affects the expression of NRP2 mRNA | 16399490 |
| C000625835 | HFPO2 compound | HFPO2 compound results in increased expression of NRP2 mRNA | 27553808 |
| C000625836 | HFPO4 compound | HFPO4 compound results in increased expression of NRP2 mRNA | 27553808 |
| D017313 | Fenretinide | Fenretinide results in increased expression of NRP2 mRNA | 28973697 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRP2 mRNA | 28628672 |
| D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of NRP2 mRNA | 25613284 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRP2 mRNA | 28628672 |
| D007608 | Kainic Acid | NRP2 protein affects the susceptibility to Kainic Acid | 18657176 |
| D058185 | Magnetite Nanoparticles | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NRP2 mRNA | 26378955 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of NRP2 mRNA | 23179753|2627250 |
| C004925 | methylmercuric chloride | "[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA" | 27188386 |
| D008767 | Methylmercury Compounds | Methylmercury Compounds results in increased expression of NRP2 mRNA | 21664453 |
| C500085 | muraglitazar | muraglitazar results in decreased expression of NRP2 mRNA | 21515302 |
| C064769 | N-acetylsphingosine | sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of NRP2 mRNA] | 15741222 |
| C017096 | n-butoxyethanol | n-butoxyethanol results in decreased expression of NRP2 mRNA | 19812364 |
| D009532 | Nickel | Nickel results in increased expression of NRP2 mRNA | 24768652 |
| C029938 | nickel sulfate | nickel sulfate results in decreased expression of NRP2 mRNA | 18832182 |
| C029938 | nickel sulfate | nickel sulfate results in increased expression of NRP2 mRNA | 16780908 |
| C009618 | O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate | "O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in decreased expression of NRP2 mRNA" | 21673326 |
| C009618 | O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate | "PON1 protein affects the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in decreased expression of NRP2 mRNA]" | 21673326 |
| D010126 | Ozone | [Ozone co-treated with Chlorine] results in increased expression of NRP2 mRNA | 18636392 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA" | 27188386 |
| D010278 | Parathion | Parathion results in increased methylation of NRP2 promoter | 22847954 |
| C568608 | PCI 5002 | [PCI 5002 co-treated with Zinc] results in increased expression of NRP2 mRNA | 18593933 |
| D010433 | Pentylenetetrazole | NRP2 protein affects the susceptibility to Pentylenetetrazole | 18657176 |
| D010634 | Phenobarbital | Phenobarbital affects the expression of NRP2 mRNA | 23091169 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of NRP2 mRNA | 26272509 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of NRP2 mRNA | 18301758|2081375 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of NRP2 mRNA | 12832660 |
| D059808 | Polyphenols | Polyphenols results in decreased expression of NRP2 mRNA | 16293270 |
| C035988 | procymidone | procymidone results in decreased expression of NRP2 mRNA | 15686871 |
| C089730 | rosiglitazone | rosiglitazone results in decreased expression of NRP2 mRNA | 21515302 |
| C410733 | scriptaid | scriptaid affects the expression of NRP2 mRNA | 18813790 |
| D012822 | Silicon Dioxide | Silicon Dioxide results in decreased expression of NRP2 mRNA | 25351596 |
| C009277 | sodium arsenate | sodium arsenate results in decreased expression of NRP2 mRNA | 21795629 |
| C017947 | sodium arsenite | sodium arsenite affects the methylation of NRP2 gene | 28589171 |
| C060506 | sphingosine 1-phosphate | sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of NRP2 mRNA] | 15741222 |
| C060506 | sphingosine 1-phosphate | sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of NRP2 mRNA] | 15741222 |
| D004113 | Succimer | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NRP2 mRNA | 26378955 |
| D013629 | Tamoxifen | Tamoxifen results in increased expression of NRP2 mRNA | 25123088 |
| C012568 | terbufos | terbufos results in increased methylation of NRP2 promoter | 22847954 |
| C501413 | tesaglitazar | tesaglitazar results in decreased expression of NRP2 mRNA | 21515302 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of NRP2 mRNA | 21570461|2637764 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of NRP2 mRNA | 25613284 |
| D013792 | Thalidomide | sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of NRP2 mRNA] | 15741222 |
| D013853 | Thioacetamide | Thioacetamide results in increased expression of NRP2 mRNA | 23411599 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in decreased expression of NRP2 mRNA | 28111298 |
| D014241 | Trichloroethylene | Trichloroethylene results in increased expression of NRP2 mRNA | 25549359 |
| D014241 | Trichloroethylene | Trichloroethylene results in increased methylation of NRP2 gene | 27618143 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A results in increased expression of NRP2 mRNA | 24935251|2627250 |
| C057693 | troglitazone | troglitazone results in decreased expression of NRP2 mRNA | 28973697 |
| C057693 | troglitazone | troglitazone results in decreased expression of NRP2 mRNA | 21515302 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of NRP2 mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of NRP2 mRNA | 24935251 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of NRP2 mRNA | 23179753|2438349 |
| D014638 | Vanadates | Vanadates results in increased expression of NRP2 mRNA | 22714537 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in decreased methylation of NRP2 gene | 25560391 |
| C025643 | vinclozolin | vinclozolin affects the expression of NRP2 mRNA | 19015723 |
| C025643 | vinclozolin | vinclozolin results in decreased expression of NRP2 mRNA | 15686871 |
| C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA" | 27188386 |
| C111237 | vorinostat | vorinostat results in increased expression of NRP2 mRNA | 26272509 |
| D015032 | Zinc | [PCI 5002 co-treated with Zinc] results in increased expression of NRP2 mRNA | 18593933 |